Certainly. Below is a **detailed and comprehensive summary** of the provided regulation, with clear organization, context, and interpretation â€” despite the fact that significant portions of the text have been **repealed** (as indicated by "Repealed, SOR/2019-134").

---

## ğŸ” **Detailed Summary of the Fees in Respect of Drugs and Medical Devices Regulations (as originally enacted and prior to repeal)**  
*Regulation S.C. 2004, c. 6; Amended under S.C. 1991, c. 24, s. 6 and s. 7(2); Repealed in part by SOR/2019-134*

---

### ğŸ“Œ **1. Legal Authority and Enactment Background**

- The regulation was made by **His Excellency the Governor General in Council**, acting on the **recommendation of the Treasury Board and the Minister of Health**.
- It is authorized under:
  - **Subsection 19(1)b** and **Section 19.1b** of the *Financial Administration Act* (FAA)
  - **Subsection 23(2.1)d** of the FAA, which allows the regulation to be made in the public interest.
- The requirement under **Section 4 of the User Fees Act** (i.e., compliance with fee-setting procedures) has been met.

> âœ… This means the fees were not arbitrary or procedurally flawed â€” they were established through proper legislative and administrative processes.

---

### ğŸ¯ **2. Purpose of the Regulations**

The primary purposes are:

1. **To prescribe fees** for:
   - The examination of an application for a **dealerâ€™s licence**
   - The **renewal** of a dealerâ€™s licence

   These licences are governed under:
   - **Part G of the Food and Drug Regulations** (for general drug dealers)
   - **The Narcotic Control Regulations** (for controlled substances)

2. **To remit (reduce or waive) certain portions of these fees**, based on financial circumstances.

> âš ï¸ *Note: The remission provisions have been partially repealed by SOR/2019-134, s. 5.*

---

### ğŸ’° **3. Fee Structure**

- The base fee for:
  - Applying for a **dealerâ€™s licence**
  - Renewing a dealerâ€™s licence  
  is **$4,510 per premise** (location) where activities will be conducted.

> Example: If a business operates in two locations, the total fee would be $9,020.

---

### ğŸ“‰ **4. Fee Adjustment Mechanism**

- The fee is **increased annually by 2%**, rounded **up to the nearest dollar**.
- The adjustment begins on **April 1, 2012**.

> Example:  
> - 2012 fee: $4,510  
> - 2013 fee: $4,510 Ã— 1.02 = $4,600.20 â†’ rounded up to **$4,601**  
> - This process continues each year.

> âš ï¸ *This provision has been repealed by SOR/2019-134, s. 7.*

---

### ğŸ“ **5. Definitions (Applicable to Sections 30, 31, and 33)**

| Term | Definition |
|------|-----------|
| **Dealerâ€™s licence** | A licence issued under either: <br> - Section G.02.007 of the Food and Drug Regulations <br> - Section 10.1 of the Narcotic Control Regulations |
| **Health care facility** | A facility providing diagnostic or therapeutic services to patients. Includes a group of facilities under common management. |
| **Controlled drug / Narcotic** | As defined in the *Controlled Drugs and Substances Act* (CDSA) â€” not fully defined here but assumed to refer to drugs subject to strict regulation. |

> All other terms are defined in the *Controlled Drugs and Substances Act*, *Food and Drug Regulations*, or *Narcotic Control Regulations*.

---

### ğŸš« **6. Exclusions (When the Regulations Do Not Apply)**

The fees **do not apply** to:

1. **Publicly funded health care facilities** (e.g., government hospitals or public clinics)
2. **Government entities** (branches or agencies of the Government of Canada or a province)
3. **Organizations engaged solely in scientific investigation** (e.g., research labs without commercial distribution)
4. **Drugs intended for veterinary use only**

> These exclusions ensure that public services and non-commercial research are not burdened by licensing fees.

---

### ğŸ’¡ **7. Remission of Fees (Fee Waiver)**

A key feature is the **remission mechanism** to prevent undue financial burden on small or new businesses.

#### Conditions for Remission:
- If the applicantâ€™s **actual gross revenue** from activities under the licence during the **previous calendar year** is **less than 1%** of the base fee ($4,510), then:
  - The applicant can claim **remission** of the **difference** between the fee and 1% of their actual revenue.
- The applicant must provide a **statement signed by the individual responsible for financial affairs** stating their actual gross revenue.

> Example:  
> - Base fee = $4,510  
> - 1% of base fee = $45.10  
> - If applicantâ€™s actual revenue = $30,000 â†’ 1% = $300 â†’ exceeds $45.10 â†’ no remission  
> - If actual revenue = $100 â†’ 1% = $10 â†’ less than $45.10 â†’ remission of $35.10

> âš ï¸ *This remission clause was repealed by SOR/2019-134, s. 5.*

---

### ğŸ“… **8. Payment Timing and Deferral**

- The fee is payable **at the time of submitting** the application.
- However, if the applicant has **not completed their first full calendar year** of operations under the licence:
  - The fee is **deferred until the end of that year**.

> This allows new businesses to start operations without immediate financial pressure.

> âš ï¸ *This deferral rule was repealed by SOR/2019-134, s. 14.*

---

### ğŸ” **9. Auditor Requirement and Enforcement (Conditional on Remission)**

If the Minister determines the financial statement provided under section 31(2) is **inadequate**, the Minister may require the applicant to provide:

- **Audited sales records** from a **qualified independent auditor**.

#### Timeline:
- The applicant has **60 days** to submit the audited records after the Ministerâ€™s request.

#### Consequences of Non-Compliance:
- If records are **not submitted within 60 days**:
  - The **difference between the fee due and the amount already paid** becomes **immediately payable**.
- If audited records show:
  - The amount paid is **less than the actual fee** â†’ **difference is immediately payable**.
  - The amount paid is **greater than the actual fee** â†’ **remission is granted**, and the Minister **must repay** the excess.

> âš ï¸ *This section was repealed by SOR/2019-134, s. 15.*

---

### ğŸ“… **10. Effective Date and Continuation Provisions**

- The regulations came into force on **April 1, 2011**.
- If registered after that date, they come into force on the **date of registration**.

> âš ï¸ **Critical Continuation Clause (Post-Repeal):**  
> Even after repeal, the **previous version of the regulations** continues to apply in certain cases:
> - Fees deferred under specific subsections (e.g., 9(1), 10, 17(4), 35(4), 43(1), 48(3), 51(4))
> - Remissions under specific sections (e.g., 11, 17(2), 44, 51(2))

> This ensures **continuity of obligations** for existing applications or deferred payments.

---

### âŒ **Important Note on Repeal**

The regulation was **partially repealed** by **SOR/2019-134, s. 2, 5, 7, 14, 15**.

#### What Was Repealed:
| Section | Repealed By | Impact |
|--------|-------------|--------|
| Remission provisions (fee reduction based on revenue) | SOR/2019-134, s. 5 | No longer available |
| Annual fee increase (2%) | SOR/2019-134, s. 7 | No longer applies |
| Fee deferral for new applicants | SOR/2019-134, s. 14 | No longer applies |
| Auditor requirement and enforcement | SOR/2019-134, s. 15 | No longer applies |

> âœ… Therefore, **as of the date of SOR/2019-134**, the **core fee structure ($4,510 per premise)**